Works matching DE "IMIPENEM"


Results: 793
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Molecular mechanisms leading to ceftolozane/tazobactam resistance in clinical isolates of Pseudomonas aeruginosa from five Latin American countries.

    Published in:
    Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.1035609
    By:
    • Mojica, María F.;
    • De La Cadena, Elsa;
    • Ríos, Rafael;
    • Carlos García-Betancur, Juan;
    • Díaz, Lorena;
    • Reyes, Jinnethe;
    • Hernández-Gómez, Cristhian;
    • Radice, Marcela;
    • Gales, Ana C.;
    • Castañeda Méndez, Paulo;
    • Munita, José M.;
    • José Pallares, Christian;
    • Martínez, José R. W.;
    • Virginia Villegas, María
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Antipseudomonal β-Lactams Resistance in Iran.

    Published in:
    International Journal of Microbiology, 2020, p. 1, doi. 10.1155/2020/8818315
    By:
    • Rabiei, Mohammad Mahdi;
    • Asadi, Keivan;
    • Shokouhi, Shervin;
    • Nasiri, Mohammad Javad;
    • Alavi Darazam, Ilad
    Publication type:
    Article
    36
    37
    38
    39
    40
    41

    Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).

    Published in:
    PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0198621
    By:
    • Ponce-de-Leon, Alfredo;
    • Rodríguez-Noriega, Eduardo;
    • Morfín-Otero, Rayo;
    • Cornejo-Juárez, Dora P.;
    • Tinoco, Juan C.;
    • Martínez-Gamboa, Areli;
    • Gaona-Tapia, Carmen J.;
    • Guerrero-Almeida, M. Lourdes;
    • Martin-Onraët, Alexandra;
    • Vallejo Cervantes, José Luis;
    • Sifuentes-Osornio, José
    Publication type:
    Article
    42
    43
    44

    Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Children with Confirmed or Suspected Gram‐Negative Bacterial Infections: A Phase 1b, Open‐Label, Single‐Dose Clinical Trial.

    Published in:
    Journal of Clinical Pharmacology, 2023, v. 63, n. 12, p. 1387, doi. 10.1002/jcph.2334
    By:
    • Bradley, John S.;
    • Makieieva, Nataliia;
    • Tøndel, Camilla;
    • Roilides, Emmanuel;
    • Kelly, Matthew S.;
    • Patel, Munjal;
    • Vaddady, Pavan;
    • Maniar, Alok;
    • Zhang, Ying;
    • Paschke, Amanda;
    • Chen, Luke F.
    Publication type:
    Article
    45
    46
    47

    Activity of imipenem/relebactam against Enterobacterales and Pseudomonas aeruginosa in Spain. SMART 2016-2020.

    Published in:
    Revista Española de Quimioterapia, 2023, v. 36, n. 3, p. 302, doi. 10.37201/req/007.2023
    By:
    • García-Fernández, Sergio;
    • Calvo, Jorge;
    • Cercenado, Emilia;
    • Suárez-Barrenechea, Ana Isabel;
    • Fernández-Billón, María;
    • Javier Castillo, Francisco;
    • Gálvez-Benítez, Lydia;
    • Tubau, Fe;
    • Figueroa Cerón, Ruth Esther;
    • Hernández-Cabezas, Alicia;
    • González Romo, Fernando;
    • Carmen Fariñas, María;
    • Gómez, María;
    • Díaz-Regañón, Jazmín;
    • Cantón, Rafael
    Publication type:
    Article
    48
    49
    50